• Facebook
  • Twitter

2nd WHO Model List of Essential in vitro diagnostic (EDL), was launched today in the United Nations press conference.

On the 9th July WHO launched the 2nd WHO Model List of Essential in vitro diagnostic along with the 21st Essential Medicines list.

WHO is thankful to the members of the Strategic Advisory group  (SAGE IVD) for their knowledge and expertise and to all those that were involved in the review, development and submissions of tests.

The objective of the EDL is to increase access, affordability, availability of these tests globally, to support universal health coverage and better health for all .

WHO presents  the second EDL which is describes in vitro diagnostic tests for two tiers:

  1. Community and health settings without laboratories, and
  2. Health care facilities with clinical laboratories.

It consists of 122 test categories presented as follows:

  • 46 general IVD tests that can be used for routine patient care as well as for the detection and diagnosis of a wide array of disease conditions;
  • 69 IVDs intended for the detection, diagnosis and monitoring of specific diseases. The second EDL extends the diseases to include noncommunicable diseases, with an extensive new section covering cancer tests as well as a set of general tests, including a new anatomical pathology section; and
  • 7 test categories intended for screening of blood donations.

More information on the 3 EDL  list can be found here.

WHO opens today the call for applications to the 3rd EDL, (deadline 8 September 2019),  to add more in vitro diagnostic tests for emergencies, neglected tropical diseases, outbreaks, antimicrobial resistance, point of care technologies, non communicable diseases…  more information for submissions

WHO  is aware that PDF and books are not the best option to access these lists;  today, opens a call to develop an electronic system : MEDEVIS ( medical devices information system) including e- EDL,  to manage, disseminate, update and consult the information of EDL and of WHO Priority medical devices lists.

The  RFP has just been published on UNGM: https://www.ungm.org/Public/Notice/93502 and closes 14 August, 2019.

To continue this work , WHO will be hiring and will soon  be posting a 9 month position (1903201) :

Objective of the post: To work within the Essential  in vitro Diagnostic List (EDL) Secretariat,  support the technical communication with the members of the Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD) and technical counterparts in WHO on IVDs, particularly on those required for non-communicable diseases (NCDs).


Essential:  Advanced university degree in biomedical sciences, laboratory medicine, pathology; biology, biomedical engineer specialized in laboratory equipment, or other related scientific field with experience including non-communicable diseases.

Desirable: Advanced university degree (masters level) in pathology, laboratory medicine, biomedical engineering, health technology assessment, public health, health economics, regulation of IVDs, or other related fields.


Essential: At least seven years of relevant experience in high level management of diagnostic laboratory units, specialized in medical technology, biomedical field, clinical laboratories, in vitro diagnostic tests, clinical practice.

Desirable: Previous experience in Ministries of Health, national reference laboratories, and/or international NGOs, relevant UN or WHO. Experience with assessments/reviews and interaction with selection committees.

Interested candidates please send a CV to This email address is being protected from spambots. You need JavaScript enabled to view it. before  20th of July, and also can submit their CV and apply in the Stellis system ( might be published in the next weeks) : see  New positions under recruitment by WHO

Source: https://www.who.int/

Login Form

CMLF News Issue #7
27th January 2016